论我国转基因生物技术发展中的公众参与  

Public Participation of Genetically Modified Organisms Technology in China

作　　者：刘旭霞[1] 刘渊博[1] 

机构地区：[1]华中农业大学文法学院,湖北武汉430070

出　　处：《自然辩证法研究》2015年第5期61-66,共6页Studies in Dialectics of Nature

基　　金：国家社科重点项目"转基因农业生物技术产业化可持续发展研究"(11AZD107);中央高校基本科研业务费专项资金资助"转基因动物产业化法律制度研究"(2011RW002)

摘　　要：不同利益集团和阶层之间的沟通无效已经成为中国转基因技术发展的主要矛盾,需要有序参与的制度渠道,明确不同社会公众群体的权利义务,将公众积极性正向转化,结束"或挺或反"的无序争辩。形成普通公众与科学工作者同步参与决策、表达意见、履行对等义务的深入技术因素的科学的公众参与状态,推动中国转基因技术健康持续高效的发展,在应用程序上将技术风险降到最低,实现社会公共利益的协调。In China, the principal contradiction in development of GM technology is that different interest groups and social class can＇t commuuicate effectively,which needs an institution of normalization, determines the rights and obligations of different public groups clearly,so as to lead the enthu- siasm of the public towards social benefits, and ends the disorderly debate of ＂Support＂ or ＂Against＂. Realize a state of synchronization in decision making, opinion expression and carry out opposite obligation between the public and scientists, promoting the development of transgenic technology sustainably and efficiently in China, minimizing the risk of genetically modified organisms technology on the technical application program, and coor- dinating social interests of all parties concerned.

关 键 词：转基因 生物技术 公众参与 深入参与 

分 类 号：N031[自然科学总论—科学技术哲学]